Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells

被引:32
作者
Kurata, K. [2 ]
Yanagisawa, R. [2 ]
Ohira, M. [1 ]
Kitagawa, M. [3 ]
Nakagawara, A. [1 ]
Kamijo, T. [1 ,2 ]
机构
[1] Chiba Canc Ctr Res Inst, Div Biochem, Chuoh Ku, Chiba 2608717, Japan
[2] Shinshu Univ, Sch Med, Dept Pediat, Nagano, Japan
[3] Hamamatsu Univ Sch Med, Dept Biochem, Shizuoka, Japan
关键词
neuroblastoma; p53; noxa; mitochondria; apoptosis;
D O I
10.1038/sj.onc.1210672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we employed a panel of cell lines to determine whether p53-dependent cell death in neuroblastoma (NB) cells is caused by apoptotic cellular function, and we further studied the molecular mechanism of apoptosis induced via the p53-dependent pathway. We obtained evidence that a type of p53-dependent stress, doxorubicin (Doxo) administration, causes accumulation of p53 in the nucleus of NB cells and phosphorylation of several serine residues in both Doxo-sensitive and -resistant cell lines. Upregulation of p53-downstream molecules in cells and upregulation of Noxa in the mitochondrial fraction were observed only in Doxo-sensitive NB cells. Significance of Noxa in the Doxo-induced NB cell death was confirmed by Noxa-knockdown experiments. Mitochondrial dysfunction, including cytochrome-c release and membrane potential disregulation, occurred and resulted in the activation of the intrinsic caspase pathway. However, in the Doxo-resistant cells, the accumulation in the nucleus and phosphorylation of p53 did not induce p53-downstream p21(Cip1/Waf1) expression and the Noxa upregulation, resulting in the retention of the mitochondrial homeostasis. Taken together, these findings indicate that the p53 pathway seems to play a crucial role in NB cell death by Noxa regulation in mitochondria, and inhibition of the induction of p53-downstream effectors may regulate drug resistance of NB cells.
引用
收藏
页码:741 / 754
页数:14
相关论文
共 37 条
[1]   Nuclear factor-κB modulates the p53 response in neurons exposed to DNA damage [J].
Aleyasin, H ;
Cregan, SP ;
Iyirhiaro, G ;
O'Hare, MJ ;
Callaghan, SM ;
Slack, RS ;
Park, DS .
JOURNAL OF NEUROSCIENCE, 2004, 24 (12) :2963-2973
[2]   The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage [J].
Bell, Emma ;
Premkumar, Rakesh ;
Carr, Jane ;
Lu, Xiaohong ;
Lovat, Penny E. ;
Kees, Ursula R. ;
Lunec, John ;
Tweddle, Deborah A. .
CELL CYCLE, 2006, 5 (22) :2639-2647
[3]   Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[4]   Apoptotic pathways: Paper wraps stone blunts scissors [J].
Green, DR .
CELL, 2000, 102 (01) :1-4
[5]   Peak plasma concentrations of doxorubicin in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma [J].
Hempel, G ;
Flege, S ;
Würthwein, G ;
Boos, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (02) :133-141
[6]   MOLECULAR-CLONING AND CHARACTERIZATION OF A CDNA FOR A NOVEL PHORBOL-12-MYRISTATE-13-ACETATE-RESPONSIVE GENE THAT IS HIGHLY EXPRESSED IN AN ADULT T-CELL LEUKEMIA-CELL LINE [J].
HIJIKATA, M ;
KATO, N ;
SATO, T ;
KAGAMI, Y ;
SHIMOTOHNO, K .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4632-4639
[7]   Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells [J].
Hopkins-Donaldson, S ;
Yan, P ;
Bourloud, KB ;
Muhlethaler, A ;
Bodmer, JL ;
Gross, N .
ONCOGENE, 2002, 21 (39) :6132-6137
[8]   Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate [J].
Hudson, CD ;
Morris, PJ ;
Latchman, DS ;
Budhram-Mahadeo, VS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :11851-11858
[9]   Requirement for HDM2 activity in the rapid degradation of p53 in neuroblastoma [J].
Isaacs, JS ;
Saito, S ;
Neckers, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18497-18506
[10]  
KAMIJO T, 1993, J BIOL CHEM, V268, P26452